De-Shen Wang Selected Research

De-Shen Wang Research Topics

Disease

33	Neoplasms (Cancer) 03/2024 - 04/2013
29	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 02/2013
15	Neoplasm Metastasis (Metastasis) 05/2024 - 04/2013
12	Stomach Neoplasms (Stomach Cancer) 01/2023 - 05/2014
8	Esophageal Squamous Cell Carcinoma 01/2024 - 02/2016
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 07/2012
4	Colonic Neoplasms (Colon Cancer) 01/2019 - 09/2014
3	Nausea 01/2022 - 01/2017
3	Vomiting 01/2022 - 01/2017
3	Nasopharyngeal Carcinoma 01/2022 - 08/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 06/2014
2	Adenocarcinoma 11/2022 - 01/2019
2	Hypoxia (Hypoxemia) 01/2021 - 06/2019
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021 - 01/2020
2	Carcinogenesis 01/2019 - 01/2015
1	Esophageal Neoplasms (Esophageal Cancer) 01/2023
1	Inflammation (Inflammations) 01/2022
1	Fatigue 01/2022
1	Anemia 01/2022
1	Mucositis 01/2022
1	Hand-Foot Syndrome 01/2022
1	Disease Progression 01/2021
1	Residual Neoplasm 01/2021
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

8	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 08/2016
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 02/2013
6	Fluorouracil (Carac)FDA LinkGeneric 01/2024 - 08/2016
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2018
5	Long Noncoding RNAIBA 01/2023 - 01/2016
4	Cetuximab (Erbitux)FDA Link 05/2024 - 06/2015
4	Bevacizumab (Avastin)FDA Link 03/2024 - 02/2015
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 08/2016
4	Irinotecan (Camptosar)FDA LinkGeneric 12/2022 - 01/2018
4	Trastuzumab (Herceptin)FDA Link 11/2022 - 05/2014
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2014
3	Leucovorin (Folinic Acid)FDA Link 01/2021 - 01/2017
2	Monoclonal AntibodiesIBA 03/2024 - 05/2014
2	ChromatinIBA 03/2024 - 01/2020
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2024 - 01/2021
2	Fumarate Hydratase (Fumarase)IBA 01/2023 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 01/2022
2	LipidsIBA 01/2022 - 08/2016
2	Capecitabine (Xeloda)FDA Link 01/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	EnzymesIBA 01/2022 - 01/2020
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2021 - 02/2016
2	folfirinoxIBA 01/2021 - 01/2019
2	regorafenibIBA 01/2021 - 01/2019
2	nedaplatinIBA 01/2021 - 01/2017
2	NADP (NADPH)IBA 01/2020 - 06/2019
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 11/2013
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2019 - 06/2014
2	HDL CholesterolIBA 01/2019 - 08/2016
2	Messenger RNA (mRNA)IBA 01/2015 - 04/2013
2	ethyl acetateIBA 09/2014 - 11/2013
1	lorlatinibIBA 05/2024
1	brigatinibIBA 05/2024
1	Anaplastic Lymphoma KinaseIBA 05/2024
1	Histone Deacetylase InhibitorsIBA 03/2024
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 03/2024
1	sintilimabIBA 03/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2024
1	Histones (Histone)IBA 03/2024
1	CateninsIBA 01/2024
1	VemurafenibIBA 12/2022
1	ARX788IBA 11/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	camrelizumabIBA 01/2021
1	AntiemeticsIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Gemcitabine FDA Link 01/2021
1	Palonosetron (Aloxi)FDA Link 01/2021
1	Aprepitant (Emend)FDA Link 01/2021
1	toripalimabIBA 01/2021
1	EndostatinsIBA 01/2021
1	UbiquitinIBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 01/2021
1	N-methyladenosineIBA 01/2021
1	Apolipoproteins B (ApoB)IBA 01/2020
1	Nuclear Export Signals (Nuclear Export Signal)IBA 01/2020
1	PPAR deltaIBA 01/2020
1	TransposasesIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2020
1	Vitamin D FDA LinkGeneric 01/2020
1	PerhexilineIBA 01/2020
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2020
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 01/2020

Therapy/Procedure

21	Drug Therapy (Chemotherapy) 05/2024 - 11/2013
6	Hepatectomy 10/2023 - 12/2020
4	Induction Chemotherapy 01/2024 - 01/2022
4	Immunotherapy 11/2022 - 10/2020
3	Therapeutics 01/2022 - 12/2015
2	TP protocol 01/2022 - 01/2022
2	Salvage Therapy 01/2021 - 08/2016
2	Adjuvant Chemotherapy 01/2021 - 08/2016
1	Chemoradiotherapy 01/2022
1	Aftercare (After-Treatment) 01/2021